141 related articles for article (PubMed ID: 12714826)
1. Presence of ADAMTS13 activity in a patient with metastatic cancer and thrombotic microangiopathy.
Forman RB; Benkel SA; Novik Y; Tsai HM
Acta Haematol; 2003; 109(3):150-2. PubMed ID: 12714826
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
5. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
Tsai HM
J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343
[TBL] [Abstract][Full Text] [Related]
6. Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Case 2.
Winkler A; Kremer Hovinga JA; Bianchi V; Studt JD; Lämmle B
Hamostaseologie; 2003 Aug; 23(3):103-8. PubMed ID: 12923577
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and management of patients with thrombotic thrombocytopenic purpura.
George JN
J Intensive Care Med; 2007; 22(2):82-91. PubMed ID: 17456728
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
Vesely SK; George JN; Lämmle B; Studt JD; Alberio L; El-Harake MA; Raskob GE
Blood; 2003 Jul; 102(1):60-8. PubMed ID: 12637323
[TBL] [Abstract][Full Text] [Related]
9. Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident.
Downes KA; Yomtovian R; Tsai HM; Silver B; Rutherford C; Sarode R
J Clin Apher; 2004; 19(2):86-9. PubMed ID: 15274201
[TBL] [Abstract][Full Text] [Related]
10. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.
Zheng XL; Kaufman RM; Goodnough LT; Sadler JE
Blood; 2004 Jun; 103(11):4043-9. PubMed ID: 14982878
[TBL] [Abstract][Full Text] [Related]
11. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.
Kalish Y; Rottenstreich A; Rund D; Hochberg-Klein S
J Thromb Thrombolysis; 2016 Aug; 42(2):155-60. PubMed ID: 26867546
[TBL] [Abstract][Full Text] [Related]
12. [Thrombotic thrombocytopenic purpura. Reduced activity of von Willebrand factor cleaving protease].
Kunze A; Terborg C; Gerth J; Heide G; Witte OW
Nervenarzt; 2004 Aug; 75(8):785-9. PubMed ID: 15034657
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
Yagi H
Rinsho Byori; 2005 Jul; 53(7):630-8. PubMed ID: 16104532
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura.
Rick ME; Austin H; Leitman SF; Krizek DM; Aronson DL
Am J Hematol; 2004 Feb; 75(2):96-100. PubMed ID: 14755376
[TBL] [Abstract][Full Text] [Related]
15. What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura.
Sadler JE
Hematology Am Soc Hematol Educ Program; 2015; 2015(1):631-6. PubMed ID: 26637781
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic thrombocytopenic purpura.
Lämmle B; Kremer Hovinga J; Studt JD; Mansouri Taleghani B; Alberio L
Hematol J; 2004; 5 Suppl 3():S6-11. PubMed ID: 15190269
[No Abstract] [Full Text] [Related]
17. Atypical presentations of thrombotic thrombocytopenic purpura: a review.
Sarode R
J Clin Apher; 2009; 24(1):47-52. PubMed ID: 19073011
[TBL] [Abstract][Full Text] [Related]
18. Value of ADAMTS13 activity and inhibitor in the postmortem diagnosis of thrombotic thrombocytopenic purpura.
Dwyre DM; Dursteler B; Nashelsky M; Friedman KD; Raife TJ
J Clin Apher; 2009; 24(3):106-10. PubMed ID: 19253359
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic thrombocytopenic purpura: a moving target.
Sadler JE
Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic thrombocytopenic purpura in a newborn.
Jubinsky PT; Moraille R; Tsai HM
J Perinatol; 2003 Jan; 23(1):85-7. PubMed ID: 12556937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
